Rob Gagnon

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Rob Gagnon

Rob Gagnon is recorded as Board Member at Harvard Bioscience Inc (HBIO). Harvard Bioscience Inc reported in an 8-K filed July 17, 2025 that Rob Gagnon was appointed Board of Directors, effective July 16, 2025.

“the Company announced the appointment of Rob Gagnon and Seth Benson to the Board of Directors, effective July 16, 2025.”

Harvard Bioscience Inc Form 8-K, filed July 17, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Rob Gagnon's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Harvard Bioscience Inc (HBIO)
Board Member

SEC 8-K

Current
2025-07-16–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Harvard Bioscience Inc

HBIO

Current role

Board Member

2025-07-16–present

Leadership on record at Harvard Bioscience Inc

Other people whose current roles at this company are on record from its filings.

Former Chairman CEO
John Duke CEO, Board Member
Katherine Eade Chairman
Mark Frost CFO
Kenneth Olson COO
Bertrand Loy Board Member
Bill Snider Board Member
John D. Duke Board Member
Katherine A. Eade Board Member
Mr. William A. Snider Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Board of Directors Harvard Bioscience Inc (HBIO)
2025-07-16